<DOC>
	<DOCNO>NCT00772603</DOCNO>
	<brief_summary>Evaluation safety efficacy Oxcarbazepine XR adjunctive treatment adult partial onset seizure</brief_summary>
	<brief_title>Evaluation Efficacy Safety OXC XR Adjunctive Therapy Partial Seizures</brief_title>
	<detailed_description>Multicenter , double-blind , randomize , placebo-controlled , three-arm . parallel-group study efficacy safety extended-release oxcarbazepine treatment adult refractory partial onset epilepsy .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Oxcarbazepine</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Capable comply study procedure . Able provide write informed consent Male female age 18 65 year , inclusive . Diagnosis partial onset seizure Minimum three seizure per 28 day Receiving treatment 13 AEDs Refractory least one AED No progressive neurological condition recent MRI/CT Adequate birth control woman childbearing potential Refractory OXC reason efficacy Recent status epilepticus Recent nonepileptic seizure Current diagnosis major depression Recent suicidal plan intent one attempt Current use oxcarbazepine , felbamate &lt; 18 month , phenytoin level &gt; 15mcg/mL frequent need rescue benzodiazepine Current use sodiumlowering nonseizure medication . Clinically significant hepatic , renal , cardiovascular function History recent substance abuse Females pregnant lactating . Hypersensitivity OXC relate drug Difficulty swallow study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Partial onset epilepsy</keyword>
	<keyword>Partial onset seizure</keyword>
</DOC>